These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16574528)

  • 1. QT interval prolongation associated with venlafaxine administration.
    Letsas K; Korantzopoulos P; Pappas L; Evangelou D; Efremidis M; Kardaras F
    Int J Cardiol; 2006 Apr; 109(1):116-7. PubMed ID: 16574528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conduction disturbances associated with venlafaxine.
    Combes A; Peytavin G; Théron D
    Ann Intern Med; 2001 Jan; 134(2):166-7. PubMed ID: 11177325
    [No Abstract]   [Full Text] [Related]  

  • 3. Multifactorial QT interval prolongation.
    Digby G; Machaalany J; Malik P; Methot M; Simpson CS; Redfearn D; Baranchuk A
    Cardiol J; 2010; 17(2):184-8. PubMed ID: 20544619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged QTc interval and torsades de pointes induced by citalopram.
    Deshmukh A; Ulveling K; Alla V; Abuissa H; Airey K
    Tex Heart Inst J; 2012; 39(1):68-70. PubMed ID: 22412232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyponatremia with venlafaxine.
    Masood GR; Karki SD; Patterson WR
    Ann Pharmacother; 1998 Jan; 32(1):49-51. PubMed ID: 9475820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrocardiogram changes and arrhythmias in venlafaxine overdose.
    Isbister GK
    Br J Clin Pharmacol; 2009 May; 67(5):572-6. PubMed ID: 19552753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venlafaxine and risk of upper gastrointestinal bleeding in elderly depression.
    Ghio L; Puppo S; Presta A
    Curr Drug Saf; 2012 Nov; 7(5):389-90. PubMed ID: 23110464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular changes associated with venlafaxine in the treatment of late-life depression.
    Johnson EM; Whyte E; Mulsant BH; Pollock BG; Weber E; Begley AE; Reynolds CF
    Am J Geriatr Psychiatry; 2006 Sep; 14(9):796-802. PubMed ID: 16943176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular safety in depressed patients: focus on venlafaxine.
    Feighner JP
    J Clin Psychiatry; 1995 Dec; 56(12):574-9. PubMed ID: 8530334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of erythromycin-induced malignant tachyarrhythmia--torsade de pointes. A case report.
    Katapadi K; Kostandy G; Katapadi M; Hussain KM; Schifter D
    Angiology; 1997 Sep; 48(9):821-6. PubMed ID: 9313632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venlafaxine augmentation with lithium leading to serotonin syndrome.
    Shahani L
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):E47. PubMed ID: 23037683
    [No Abstract]   [Full Text] [Related]  

  • 15. Priapism associated with venlafaxine use.
    Samuel RZ
    J Am Acad Child Adolesc Psychiatry; 2000 Jan; 39(1):16-7. PubMed ID: 10638063
    [No Abstract]   [Full Text] [Related]  

  • 16. [Delirium during withdrawal of venlafaxine].
    van Noorden MS; Vergouwen AC; Koerselman GF
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drugs and torsade de pointes.
    Lazzara R
    Eur Heart J; 1993 Nov; 14 Suppl H():88-92. PubMed ID: 8293758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine-induced urinary incontinence resolved after switching to sertraline.
    Polimeni G; Salvo F; Cutroneo P; Nati G; Russo A; Giustini ES; Spina E
    Clin Neuropharmacol; 2005; 28(5):247-8. PubMed ID: 16239768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT interval prolongation and torsade de pointes associated with indapamide.
    Letsas KP; Alexanian IP; Pappas LK; Kounas SP; Efremidis M; Sideris A; Kardaras F
    Int J Cardiol; 2006 Oct; 112(3):373-4. PubMed ID: 16260053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    de Moor RA; Mourad L; ter Haar J; Egberts AC
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.